Next Article in Journal
Interventricular Septal Thickness as a Diagnostic Marker of Fetal Macrosomia
Next Article in Special Issue
Neurocognitive Status after Aortic Valve Replacement: Differences between TAVI and Surgery
Previous Article in Journal
Pharmacological Primary Cardiovascular Prevention and Subclinical Atherosclerosis in Men: Evidence from the Aragon Workers’ Health Study
 
 
Review

Aortic Valve Disease and Associated Complex CAD: The Interventional Approach

1
Oxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford OX3 9DU, UK
2
Department of Cardiology, University of Verona, 37129 Verona, Italy
3
Institute of Life Sciences 2, Swansea Bay University Health Board and Swansea University Medical School, SA2 8QA Swansea, UK
4
Department of Cardiology, Royal North Shore Hospital, 2065 Sydney, Australia
*
Author to whom correspondence should be addressed.
Academic Editor: Flavio Ribichini
J. Clin. Med. 2021, 10(5), 946; https://doi.org/10.3390/jcm10050946
Received: 31 January 2021 / Revised: 19 February 2021 / Accepted: 20 February 2021 / Published: 1 March 2021
Coronary artery disease (CAD) is highly prevalent in patients with severe aortic stenosis (AS). The management of CAD is a central aspect of the work-up of patients undergoing transcatheter aortic valve implantation (TAVI), but few data are available on this field and the best percutaneous coronary intervention (PCI) practice is yet to be determined. A major challenge is the ability to elucidate the severity of bystander coronary stenosis independently of the severity of aortic valve stenosis and subsequent impact on blood flow. The prognostic role of CAD in patients undergoing TAVI is being still debated and the benefits and the best timing of PCI in this context are currently under evaluation. Additionally, PCI in the setting of advanced AS poses some technical challenges, due to the complex anatomy, risk of hemodynamic instability, and the increased risk of bleeding complications. This review aims to provide a comprehensive synthesis of the available literature on myocardial revascularization in patients with severe AS undergoing TAVI. This work can assist the Heart Team in individualizing decisions about myocardial revascularization, taking into account available diagnostic tools as well as the risks and benefits. View Full-Text
Keywords: aortic stenosis; coronary artery disease; myocardial revascularization; percutaneous coronary intervention aortic stenosis; coronary artery disease; myocardial revascularization; percutaneous coronary intervention
Show Figures

Figure 1

MDPI and ACS Style

Marin, F.; Scarsini, R.; Kotronias, R.A.; Terentes-Printzios, D.; Burrage, M.K.; Bray, J.J.H.; Ciofani, J.L.; Venturi, G.; Pighi, M.; De Maria, G.L.; Banning, A.P. Aortic Valve Disease and Associated Complex CAD: The Interventional Approach. J. Clin. Med. 2021, 10, 946. https://doi.org/10.3390/jcm10050946

AMA Style

Marin F, Scarsini R, Kotronias RA, Terentes-Printzios D, Burrage MK, Bray JJH, Ciofani JL, Venturi G, Pighi M, De Maria GL, Banning AP. Aortic Valve Disease and Associated Complex CAD: The Interventional Approach. Journal of Clinical Medicine. 2021; 10(5):946. https://doi.org/10.3390/jcm10050946

Chicago/Turabian Style

Marin, Federico, Roberto Scarsini, Rafail A. Kotronias, Dimitrios Terentes-Printzios, Matthew K. Burrage, Jonathan J. H. Bray, Jonathan L. Ciofani, Gabriele Venturi, Michele Pighi, Giovanni L. De Maria, and Adrian P. Banning. 2021. "Aortic Valve Disease and Associated Complex CAD: The Interventional Approach" Journal of Clinical Medicine 10, no. 5: 946. https://doi.org/10.3390/jcm10050946

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop